Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/216495
Title: Health-related quality of life in long-term colorectal cancer survivors
Author: Marcos Delgado, Alba
Martín Sánchez, Vicente
Molina Barceló, Ana
Alonso-Molero, Jéssica
Pérez Gómez, Beatriz
Aragonés, Nuria
Ederra-Sanza, María
Fernández-Tardón, Guillermo
Binefa i Rodríguez, Gemma
Moreno Aguado, Víctor
Barrios-Rodríguez, Rocío
Amiano, Pilar
Pastor Teso, Enrique
Alguacil, Juan
Castaño-Vinyals, Gemma
Kogevinas, Manolis
Molina de la Torre, Antonio José
Pollán, Marina
Huerta Castaño, José María
Keywords: Qualitat de vida
Càncer colorectal
Mortalitat
Quality of life
Colorectal cancer
Mortality
Issue Date: 25-Sep-2024
Publisher: MDPI
Abstract: The aim of our study is to evaluate the relationship between sociodemographic and clinical characteristics of individuals with Colorectal Cancer (CRC), tumour-intrinsic characteristics and treatment received with health-related quality of life (HRQoL). Methods: Cross-sectional analysis of data from 805 survivors from the MCC study was conducted. HRQoL was assessed through a general and specific questionnaire, SF-12 and FCSI (Colorectal Symptom Index). Statistical analyses were performed with linear regression with adjustment for sociodemographic variables, stage at diagnosis and histological grade. Results: Participants had survived a median of 7.9 years from diagnosis (IQR 7.1-8.5 years). Age at diagnosis, sex and area showed a clear association with HRQoL in both physical and mental dimensions of the SF-12 questionnaire. A direct association between CRC recurrence was also found in the PCS-12 and MCS-12 dimensions and radical surgery in the PCS-12. Regarding the scores in FCSI questionnaire, statistically significant differences were observed by sex, age and area, with older women being the most impaired (p < 0.001). Conclusions: Age, sex and area was associated with lower scores of HRQoL among CRC survivors. Knowing the determinants related to HRQoL would allow us to lay the groundwork to develop strategies that help reduce morbidity and mortality, relapses and increase HRQoL.
Note: Reproducció del document publicat a: https://doi.org/10.3390/healthcare12191917
It is part of: Healthcare, 2024, vol. 12, num.19
URI: https://hdl.handle.net/2445/216495
Related resource: https://doi.org/10.3390/healthcare12191917
ISSN: 2227-9032
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
870397.pdf651.55 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons